You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Suppliers and packagers for MILOPHENE


✉ Email this page to a colleague

« Back to Dashboard


MILOPHENE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Granata Bio Corp MILOPHENE clomiphene citrate TABLET;ORAL 072196 ANDA Burel Pharmaceuticals, LLC 35573-470-30 30 TABLET in 1 BOTTLE (35573-470-30) 2025-08-15
Granata Bio Corp MILOPHENE clomiphene citrate TABLET;ORAL 072196 ANDA Burel Pharmaceuticals, LLC 35573-470-75 10 TABLET in 1 BOTTLE (35573-470-75) 2025-08-15
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Milophene

Last updated: September 26, 2025

Introduction

Milophene, also known by its chemical name 2,4-Dichlorophenoxyacetic acid (2,4-D), has historically been recognized for various applications, including as a herbicide. However, in some regions or contexts, "Milophene" could refer to alternative pharmaceutical formulations or proprietary compounds. It is essential to clarify the context—whether Milophene is targeted as a therapeutic agent, a chemical intermediate, or an industrial herbicide—since supplier landscapes differ markedly across these categories.

This article provides a comprehensive overview of potential suppliers for Milophene, emphasizing pharmaceutical-grade procurement, relevant market players, supply chain dynamics, and regional considerations. It aims to inform pharmaceutical companies, regulatory bodies, and investors on sourcing options, highlight key players, and guide strategic decision-making.


Understanding Milophene: Chemical and Usage Context

Chemical Profile

Milophene (2,4-Dichlorophenoxyacetic acid) is a chlorinated organic compound primarily used as a selective herbicide. Its relevance in pharmaceuticals is limited; if "Milophene" refers to a proprietary pharmaceutical compound, an alternative designation or registration information may be necessary.

Pharmaceutical versus Industrial Use

  • Industrial Use: Predominantly as a herbicide for agriculture, with major suppliers including diverse chemical producers specializing in agrochemicals.
  • Pharmaceutical Use: If Milophene is indicative of a pharmaceutical compound, the supply chain involves highly regulated chemical suppliers complying with Good Manufacturing Practices (GMP), with sourcing from reputable chemical manufacturers or authorized wholesalers.

Global Suppliers and Manufacturers

1. Major Chemical and Agrochemical Suppliers

BASF SE

  • Overview: A leading chemical giant, BASF supplies raw chemicals such as 2,4-D to agrochemical producers.
  • Supply Focus: Bulk chemicals, technical-grade 2,4-D, and derivative products.
  • Relevance for Pharmaceuticals: Generally, BASF’s chemicals are used industrially; pharmaceutical-grade procurement requires further purification and validation.

Dow AgroSciences (Dow Chemical)

  • Overview: A prominent producer of 2,4-D herbicides, offering technical-grade materials.
  • Supply Focus: Commercial-grade 2,4-D for herbicide manufacturing.

Syngenta AG

  • Overview: Supplier of crop protection products, including formulations based on 2,4-D.
  • Potential for Supply: Usually limited to formulation rather than raw chemicals, but may offer intermediates.

Bayer CropScience

  • Overview: Provides herbicide active ingredients, including 2,4-D compounds.
  • Supply Focus: Primarily formulated products, but also raw chemical materials.

2. Specialized Chemical Distributors

Manufacturers and distributors specializing in chemical intermediates and research-grade chemicals are crucial for pharmaceutical applications. Companies such as:

  • Sigma-Aldrich (Merck Group)
  • TCI Chemicals
  • Alfa Aesar

offer high-purity chemicals, including active pharmaceutical ingredients (APIs) and intermediates.

Note: Such distributors may not always carry Milophene directly but can source or synthesize analogous compounds or purify bulk chemicals for pharmaceutical standards.

3. Contract Manufacturing and Custom Synthesis

  • ChemLink India, Evonik, and other CDMOs (Contract Development and Manufacturing Organizations) often develop custom synthetic routes to produce active pharmaceutical ingredients (APIs).

  • Key Consideration: For pharmaceutical-grade Milophene, engaging a manufacturer with GMP certification and proven API synthesis capability is essential.


Regional Supplier Perspectives

North America

  • The United States and Canada host numerous suppliers specializing in agrochemical chemicals, with companies like BASF, Dow Chemical, and Bayer offering bulk chemicals or formulations.

  • Pharmaceutical-grade chemicals are available through distributors such as Sigma-Aldrich or directly from certified API producers.

Europe

  • Europe boasts stringent chemical regulations, with suppliers such as BASF, Syngenta, and Evonik providing high-quality chemicals.

  • Supplier selection must emphasize compliance with EMA or EMA guidelines, especially for pharmaceuticals.

Asia-Pacific

  • Countries like India, China, and South Korea are notable for both agrochemical manufacturing and chemical synthesis capabilities.

  • Companies such as GCIB (India), Huaxing Chemical (China), and Samsung (South Korea) can produce bulk chemicals, but specific pharmaceutical-grade procurement depends on certification and verification processes.


Supply Chain and Sourcing Strategies

Regulatory Compliance

For pharmaceutical applications, sourcing from suppliers with GMP accreditation or GDUFA (U.S. Food and Drug Administration) registration is mandatory to ensure purity, safety, and consistency.

Quality Certifications

Supplying companies should provide certificates of analysis (CoA), stability data, and compliance documentation aligning with pharmacopeia standards such as USP, EP, or JP.

Supply Chain Reliability

  • Establish long-term relationships with verified suppliers to ensure uninterrupted supply.
  • Incorporate dual sourcing strategies to mitigate risks associated with geopolitical or regulatory disruptions.

Customization and Contract Synthesis

  • For unique formulations or specific purity requirements, engaging CDMOs for custom synthesis offers tailored solutions.
  • Such partnerships enable scalable production while maintaining regulatory standards.

Emerging Trends and Future Outlook

  • Green Chemistry Initiatives: Growing interest in environmentally sustainable synthesis methods could influence supplier offerings.
  • Regulatory Harmonization: Increasing global regulatory convergence simplifies procurement, especially for pharmaceutical APIs.
  • Digital Sourcing Platforms: Platforms like ChemLinked or PharmaChem facilitate real-time supplier verification and procurement.

Key Takeaways

  • The raw chemical counterparts of Milophene are predominantly supplied by large agrochemical manufacturers such as BASF, Dow, and Syngenta, mainly for industrial use.
  • For pharmaceutical-grade Milophene, sourcing options are limited to specialized chemical suppliers and contract manufacturers with strict regulatory compliance.
  • Regional considerations significantly influence supplier availability, with Europe and North America emphasizing GMP standards, while Asia offers cost-effective bulk chemical synthesis.
  • Establishing partnerships with verified, GMP-compliant suppliers and utilizing digital sourcing platforms enhances supply chain security.
  • Engaging CDMOs for customized synthesis ensures purity, compliance, and scalability tailored to pharmaceutical applications.

FAQs

1. Is Milophene available as a pharmaceutical active ingredient?
Currently, Milophene (2,4-D) is primarily used as an herbicide. Its use as a pharmaceutical active ingredient is limited; procurement would require verification with specialized chemical suppliers and adherence to regulatory standards.

2. Which suppliers provide pharmaceutical-grade Milophene?
Few suppliers advertise Milophene explicitly for pharmaceutical use. Sourcing typically involves high-purity chemical manufacturers or custom synthesis through certified CDMOs capable of meeting GMP standards.

3. How do I verify the quality of Milophene from suppliers?
Request Certificates of Analysis (CoA), batch records, and regulatory compliance documentation. Ensure certifications align with pharmacopeial standards such as USP, EP, or JP.

4. Are there regional differences in sourcing Milophene?
Yes; North America and Europe enforce stringent regulations favoring GMP-certified sources, whereas Asia may offer cost advantages but requires careful verification of quality and compliance.

5. What are the considerations for establishing a supply chain for Milophene?
Prioritize supplier credibility, certification status, regulatory compliance, supply reliability, and the ability to customize specifications. Establishing long-term relationships mitigates risks and ensures consistent supply.


References

[1] Chemical Industry Data on 2,4-D: ChemSpider, Royal Society of Chemistry.
[2] Global Agrochemical Market Reports: MarketsandMarkets.
[3] Regulatory standards for pharmaceuticals: U.S. FDA, EMA guidelines.
[4] Supplier Websites and Catalogs: BASF, Dow, Sigma-Aldrich, TCI Chemicals.
[5] Industry reports on chemical sourcing strategies: ICIS, Chemical Week.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.